共 45 条
- [1] Lehto M., Haukka J., Aro A., Halminen O., Putaala J., Linna M., Et al., Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland, Open Heart, 9, (2022)
- [2] Lip G.Y.H., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J.G.M., Andresen D., Et al., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation, Chest, 137, (2010)
- [3] Bjorck S., Palaszewski B., Friberg L., Bergfeldt L., Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study, Stroke, 44, (2013)
- [4] Libby P., Buring J.E., Badimon L., Hansson G.K., Deanfield J., Bittencourt M.S., Et al., Atherosclerosis (primer), Nat. Rev. Dis. Prim., 5, (2019)
- [5] Song P., Rudan D., Zhu Y., Fowkes F.J.I., Rahimi K., Fowkes F.G.R., Et al., Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis, Lancet Global Health, 7, (2019)
- [6] Mone P., Morgante M., Pansini A., Jankauskas S.S., Rizzo M., Lombardi A., Et al., Effects of insulin resistance on mitochondrial (dys)function, Atherosclerosis, 341, (2022)
- [7] Gambardella J., Wang X., Mone P., Khondkar W., Santulli G., Genetics of adrenergic signaling drives coronary artery calcification, Atherosclerosis, 310, (2020)
- [8] Frostegard J., Immunity, atherosclerosis and cardiovascular disease, BMC Med., 11, (2013)
- [9] Raggi P., Genest J., Giles J.T., Rayner K.J., Dwivedi G., Beanlands R.S., Et al., Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions, Atherosclerosis, 276, (2018)
- [10] Song P., Fang Z., Wang H., Cai Y., Rahimi K., Zhu Y., Et al., Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study, Lancet Global Health, 8, (2020)